These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 32473243)
1. MiR-182-5p inhibits colon cancer tumorigenesis, angiogenesis, and lymphangiogenesis by directly downregulating VEGF-C. Yan S; Wang H; Chen X; Liang C; Shang W; Wang L; Li J; Xu D Cancer Lett; 2020 Sep; 488():18-26. PubMed ID: 32473243 [TBL] [Abstract][Full Text] [Related]
2. miR-503-5p inhibits colon cancer tumorigenesis, angiogenesis, and lymphangiogenesis by directly downregulating VEGF-A. Wei L; Sun C; Zhang Y; Han N; Sun S Gene Ther; 2022 Feb; 29(1-2):28-40. PubMed ID: 32533103 [TBL] [Abstract][Full Text] [Related]
3. microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C. Hu J; Cheng Y; Li Y; Jin Z; Pan Y; Liu G; Fu S; Zhang Y; Feng K; Feng Y Eur J Cancer; 2014 Sep; 50(13):2336-50. PubMed ID: 25001183 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-431-5p inhibits angiogenesis, lymphangiogenesis, and lymph node metastasis by affecting TGF-β1/SMAD2/3 signaling via ZEB1 in gastric cancer. Liu P; Ding P; Yang J; Wu H; Wu J; Guo H; Yang P; Tian Y; Meng L; Zhao Q Mol Carcinog; 2024 Jul; 63(7):1378-1391. PubMed ID: 38656643 [TBL] [Abstract][Full Text] [Related]
5. circNFIB1 inhibits lymphangiogenesis and lymphatic metastasis via the miR-486-5p/PIK3R1/VEGF-C axis in pancreatic cancer. Kong Y; Li Y; Luo Y; Zhu J; Zheng H; Gao B; Guo X; Li Z; Chen R; Chen C Mol Cancer; 2020 May; 19(1):82. PubMed ID: 32366257 [TBL] [Abstract][Full Text] [Related]
6. miR-873-5p inhibits the progression of colon cancer via repression of tumor suppressor candidate 3/AKT signaling. Zhu Y; Zhang X; Qi M; Zhang Y; Ding F J Gastroenterol Hepatol; 2019 Dec; 34(12):2126-2134. PubMed ID: 31039290 [TBL] [Abstract][Full Text] [Related]
7. CCL5 promotes VEGF-C production and induces lymphangiogenesis by suppressing miR-507 in human chondrosarcoma cells. Wang LH; Lin CY; Liu SC; Liu GT; Chen YL; Chen JJ; Chan CH; Lin TY; Chen CK; Xu GH; Chen SS; Tang CH; Wang SW Oncotarget; 2016 Jun; 7(24):36896-36908. PubMed ID: 27166194 [TBL] [Abstract][Full Text] [Related]
8. miR-145-5p restrained cell growth, invasion, migration and tumorigenesis via modulating RHBDD1 in colorectal cancer via the EGFR-associated signaling pathway. Niu Y; Zhang J; Tong Y; Li J; Liu B Int J Biochem Cell Biol; 2019 Dec; 117():105641. PubMed ID: 31693935 [TBL] [Abstract][Full Text] [Related]
9. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways. Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174 [TBL] [Abstract][Full Text] [Related]
10. miR-20b-5p functions as tumor suppressor microRNA by targeting cyclinD1 in colon cancer. Yang H; Lin J; Jiang J; Ji J; Wang C; Zhang J Cell Cycle; 2020 Nov; 19(21):2939-2954. PubMed ID: 33044899 [TBL] [Abstract][Full Text] [Related]
11. A potential small-molecule synthetic antilymphangiogenic agent norcantharidin inhibits tumor growth and lymphangiogenesis of human colonic adenocarcinomas through blocking VEGF-A,-C,-D/VEGFR-2,-3 "multi-points priming" mechanisms in vitro and in vivo. Li XP; Jing W; Sun JJ; Liu ZY; Zhang JT; Sun W; Zhu W; Fan YZ BMC Cancer; 2015 Jul; 15():527. PubMed ID: 26187792 [TBL] [Abstract][Full Text] [Related]
12. WISP-1 promotes VEGF-C-dependent lymphangiogenesis by inhibiting miR-300 in human oral squamous cell carcinoma cells. Lin CC; Chen PC; Lein MY; Tsao CW; Huang CC; Wang SW; Tang CH; Tung KC Oncotarget; 2016 Mar; 7(9):9993-10005. PubMed ID: 26824419 [TBL] [Abstract][Full Text] [Related]
13. Breast cancer cell-derived extracellular vesicles transfer miR-182-5p and promote breast carcinogenesis via the CMTM7/EGFR/AKT axis. Lu C; Zhao Y; Wang J; Shi W; Dong F; Xin Y; Zhao X; Liu C Mol Med; 2021 Jul; 27(1):78. PubMed ID: 34294040 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-27b, microRNA-101 and microRNA-128 inhibit angiogenesis by down-regulating vascular endothelial growth factor C expression in gastric cancers. Liu HT; Xing AY; Chen X; Ma RR; Wang YW; Shi DB; Zhang H; Li P; Chen HF; Li YH; Gao P Oncotarget; 2015 Nov; 6(35):37458-70. PubMed ID: 26460960 [TBL] [Abstract][Full Text] [Related]
15. Downregulation of miRNA-638 promotes angiogenesis and growth of hepatocellular carcinoma by targeting VEGF. Cheng J; Chen Y; Zhao P; Liu X; Dong J; Li J; Huang C; Wu R; Lv Y Oncotarget; 2016 May; 7(21):30702-11. PubMed ID: 27120793 [TBL] [Abstract][Full Text] [Related]
16. Qingjie Fuzheng Granule suppresses lymphangiogenesis in colorectal cancer via the VEGF-C/VEGFR-3 dependent PI3K/AKT pathway. Huang B; Lu Y; Gui M; Guan J; Lin M; Zhao J; Mao Q; Lin J Biomed Pharmacother; 2021 May; 137():111331. PubMed ID: 33578235 [TBL] [Abstract][Full Text] [Related]
17. miR-140-5p is negatively correlated with proliferation, invasion, and tumorigenesis in malignant melanoma by targeting SOX4 via the Wnt/β-catenin and NF-κB cascades. Zhao G; Yin Y; Zhao B J Cell Physiol; 2020 Mar; 235(3):2161-2170. PubMed ID: 31385607 [TBL] [Abstract][Full Text] [Related]
18. A viral microRNA downregulates metastasis suppressor CD82 and induces cell invasion and angiogenesis by activating the c-Met signaling. Li W; Hu M; Wang C; Lu H; Chen F; Xu J; Shang Y; Wang F; Qin J; Yan Q; Krueger BJ; Renne R; Gao SJ; Lu C Oncogene; 2017 Sep; 36(38):5407-5420. PubMed ID: 28534512 [TBL] [Abstract][Full Text] [Related]
19. Glioma stem cell-derived exosomal miR-944 reduces glioma growth and angiogenesis by inhibiting AKT/ERK signaling. Jiang J; Lu J; Wang X; Sun B; Liu X; Ding Y; Gao G Aging (Albany NY); 2021 Jul; 13(15):19243-19259. PubMed ID: 34233294 [TBL] [Abstract][Full Text] [Related]
20. Serum miR-486-5p as a diagnostic marker in cervical cancer: with investigation of potential mechanisms. Li C; Zheng X; Li W; Bai F; Lyu J; Meng QH BMC Cancer; 2018 Jan; 18(1):61. PubMed ID: 29316891 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]